Clinical Trial: Empyema Treated With tPA & DNAse

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Prospective Randomized Trial: Fibrinolysis With tPA (Tissue Plasminogen Activator) Versus tPA and DNAse in Children With Empyema

Brief Summary:

The objective of this study is to scientifically evaluate a new substrate for fibrinolysis compared to our standard tPA.

The hypothesis, driven by a recent prospective trial, is that tPA may benefit from the addition of DNAse.

The primary outcome variable between the two techniques will be length of hospitalization after initiation of treatment.

Detailed Summary:
Sponsor: Children's Mercy Hospital Kansas City

Current Primary Outcome: Length of stay [ Time Frame: 3 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Children's Mercy Hospital Kansas City

Dates:
Date Received: May 17, 2013
Date Started: January 2016
Date Completion:
Last Updated: January 27, 2016
Last Verified: January 2016